Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Terminated1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03587311Phase 2Active Not Recruiting
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more
PrincipalinvestigatorStart date: 2018-10-12
NCT03345784Phase 1Terminated
Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers
Cervical CarcinomaEndometrioid AdenocarcinomaMalignant Female Reproductive System Neoplasm+21 more
PrincipalinvestigatorStart date: 2018-05-29
NCT03367741Phase 2Active Not Recruiting
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
PrincipalinvestigatorStart date: 2018-04-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sharon Manne

Rutgers Cancer Institute of New Jersey

Related
5 trials

Shared therapeutic areas:

Malignant Female Reproductive System NeoplasmStage II Cervical Cancer AJCC v7Stage II Uterine Corpus Cancer AJCC v7+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Shannon N Westin

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Primary Peritoneal High Grade Serous AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Amir A Jazaeri

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Platinum-Resistant Ovarian CarcinomaPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Lilie L Lin

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Recurrent Cervical CarcinomaMalignant Female Reproductive System NeoplasmRecurrent Endometrial Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Emese Zsiros, MD

Roswell Park Cancer Institute

Related
4 trials

Shared therapeutic areas:

Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Roxana S. Dronca, MD

Mayo Clinic

Related
4 trials

Shared therapeutic areas:

Advanced Endometrial CarcinomaCervical Carcinoma
Similarity Score2%

Emese Zsiros

Roswell Park Cancer Institute

Related
6 trials

Shared therapeutic areas:

Fallopian Tube Endometrioid AdenocarcinomaOvarian Endometrioid Adenocarcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Recurrent Cervical CarcinomaCervical Carcinoma
Similarity Score2%

Evanthia Galanis, MD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Fallopian Tube Endometrioid AdenocarcinomaOvarian Endometrioid Adenocarcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Cervical CarcinomaVaginal Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03587311Phase 2PrincipalInvestigator

Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more
Active Not Recruiting
NCT03345784Phase 1PrincipalInvestigator

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

Cervical CarcinomaEndometrioid AdenocarcinomaMalignant Female Reproductive System Neoplasm+21 more
Terminated
NCT03367741Phase 2PrincipalInvestigator

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Active Not Recruiting

All 3 trials loaded